3 results
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
hospitalization for acute ... Drug interactions ... Ticagrelor to Prasugrel ... #ticagrelor #prasugrel ... #pharmacology #
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... agents in the acute ... In the acute/early ... #ticagrelor #prasugrel ... #pharmacology
Cangrelor - Pharmacology
Cangrelor (Kengreal) is a parenteral analogue of adenosine triphosphate
Cangrelor binds reversibly to the platelet
Cangrelor - Pharmacology ... : • Both prasugrel ... and clopidogrel, are ... Ticagrelor's half-life ... such that the drug